Image 5
Image 2
Image 3
Image 1
Image 4
focusing on the patient

Welcome to
OLM Innovations

OLM Innovations is committed to supporting the development of new and innovative diagnostic products with clear clinical benefits.

We will guide the process from inception to commercialisation, using our international network of specialists and decision makers in the medical sector to help give products the best possible chance of success.

Find out more about OLM innovations here.

Company News

rss_button
Journal of Infection publishes Martin Hoenigl paper
26/04/2013

Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis diagnosis in haematological malignancy and solid organ transplant patients.

Journal of Clinical Microbiology publishes Lewis White paper
26/04/2013

Evaluation of Real-Time PCR, Galactomannan Enzyme-Linked Immunosorbent Assay (ELISA), and a Novel Lateral-Flow Device for Diagnosis of Invasive Aspergillosis

Visit the news archive

Industry News

rss_button
Conversion of a soluble diazepam prodrug to supersaturated diazepam for rapid intranasal delivery: Kinetics and stability.
19/09/2018

Related Articles Conversion of a soluble diazepam prodrug to supersaturated diazepam for rap

Invasive Pulmonary Aspergillosis: Risks for Acquisition and Death in a Community Hospital.
19/09/2018

Related Articles Invasive Pulmonary Aspergillosis: Risks for Acquisition and Death in a Comm

Chemical Ecogenomics-Guided Discovery of Phytotoxic α-Pyrones from the Fungal Wheat Pathogen Parastagonospora nodorum.
19/09/2018

Related Articles Chemical Ecogenomics-Guided Discovery of Phytotoxic α-Pyrones from the Fung

Visit the news archive